MYELOPROLIFERATIVE NEOPLASM
Clinical trials for MYELOPROLIFERATIVE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE NEOPLASM trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to tame High-Risk bone marrow cancer
Disease control Not yet recruitingThis early-phase trial tests a new two-drug combination (pacritinib plus azacitidine) in 25 people with moderate to very high risk myelodysplastic syndrome (MDS), a bone marrow disorder. The first part finds the safest dose; the second part checks how well the combination works a…
Matched conditions: MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 26, 2026 05:41 UTC
-
Personalized Post-Transplant therapy aims to stop cancer return
Disease control Not yet recruitingThis study tests whether giving personalized maintenance therapy after a stem cell transplant can prevent cancer from coming back in people with certain blood cancers (like acute myeloid leukemia or myelodysplastic syndromes). About 450 adults will be assigned to receive or not r…
Matched conditions: MYELOPROLIFERATIVE NEOPLASM
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 19, 2026 11:59 UTC